Netherlands· NL-ba4f8f673316
Kidiamix G10% Start, oplossing voor infusie
A lösungen zur parenteralen ernährung, kombinationen product containing acetylcysteïne + alanine, (l-) + arginine, (l-) + asparaginezuur, (l-), registered in Netherlands by Fresenius Kabi Nederland B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Lösungen zur parenteralen ernährung, kombinationen is registered in 11 of 19 countries.
Countries holding a registration under ATC B05BA10 (lösungen zur parenteralen ernährung, kombinationen), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Lösungen zur parenteralen ernährung, kombinationen · ATC B05BA10
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- ACETYLCYSTEÏNE + ALANINE, (L-) + ARGININE, (L-) + ASPARAGINEZUUR, (L-)
- Manufacturer
- Fresenius Kabi Nederland B.V.
- Country
- Netherlands (NL)
- ATC code
- B05BA10
- ATC class
- Lösungen zur parenteralen Ernährung, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id113147
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
6 interactions on record for lösungen zur parenteralen ernährung, kombinationen.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lösungen zur parenteralen ernährung, kombinationen · interactions on record
6 records
- 2 severe
- 4 moderate
Most severe, free to view
- ErdafitinibL01EN01severe
- ErdafitinibL01EX16severe
- AmfetamineN06BA01moderate
- DexamfetamineN06BA02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B05BA10
Lösungen zur parenteralen ernährung, kombinationen, as other registers publish it.
- PolandAminomel 10 EBaxter Polska Sp. z o.o.
- PolandAminomel 12,5 EBaxter Polska Sp. z o.o.
- PolandAminomel NephroBaxter Polska Sp. z o.o.
- BelgiumAminomix 1 NovumFresenius Kabi
- CzechiaAMINOMIX 1 NOVUMFresenius Kabi Deutschland GmbH, Bad Homburg
- CzechiaAMINOMIX 1 NOVUMFresenius Kabi Deutschland GmbH, Bad Homburg
- CzechiaAMINOMIX 1 NOVUMFresenius Kabi Deutschland GmbH, Bad Homburg
- NetherlandsAminomix 1 Novum, oplossing voor infusieFresenius Kabi Nederland B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fc325714-69b4-4d17-8ec9-0a4e4d3b7c76 GET /v1/drugs/fc325714-69b4-4d17-8ec9-0a4e4d3b7c76?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h113147_smpc.pdf",
"strength": null,
"atc_label": "Combinations",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg113147",
"excipients": [
"NATRIUMHYDROXIDE (E 524)",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"ACETYLCYSTEÏNE",
"ALANINE, (L-)",
"ARGININE, (L-)",
"ASPARAGINEZUUR, (L-)",
"CALCIUM (Ca2+)",
"CALCIUMGLUCONAAT 1-WATER (E 578)",
"CHLORIDE (CL-)",
"CHROOM (Cr3+)",
"CHROOMTRICHLORIDE 6-WATER",
"FENYLALANINE, (L-)",
"FLUORIDE (F-)",
"GLUCOSE 1-WATER",
"GLUTAMINEZUUR (L-) (+) (E 620)",
"GLYCINE (E 640)",
"HISTIDINE, (L-)",
"ISOLEUCINE, (L-)",
"JODIDE (I-)",
"KALIUMJODIDE",
"KOPER (Cu2+)",
"KOPERSULFAAT 5-WATER",
"LEUCINE, (L-) (E 641)",
"LYSINE (L-) 1-WATER",
"MAGNESIUM (MG2+)",
"MAGNESIUM LACTAAT DIHYDRAAT",
"MANGAAN (Mn2+)",
"MANGAANDICHLORIDE 4-WATER",
"METHIONINE, (L-)",
"NATRIUM (NA+)",
"NATRIUMFLUORIDE",
"NATRIUMFLUORIDE",
"PROLINE, (L-)",
"SELENIUM (Se4+)",
"SELENIUMDIOXIDE",
"SERINE, (L-)",
"TAURINE",
"THREONINE, (L-)",
"TRYPTOFAAN, (L-)",
"TYROSINE, (L-)",
"VALINE, (L-)",
"ZINK (Zn2+)",
"ZINKDIACETAAT 2-WATER (E 650)"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h113147.pdf",
"authorised_at": "2014/08/22",
"procedure_number": "FR/H/0554/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "113147",
"additional_monitoring": "N"
}See everything about lösungen zur parenteralen ernährung, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.